PSUSA/00010865/202401
Submitted by Anonymous (not verified) on 11 October 2024 - 15:42
PSUSA/00010865/202401
Human medicines European public assessment report (EPAR): Halaven, eribulin, Date of authorisation: 17/03/2011, Revision: 31, Status: Authorised
Submitted by Anonymous (not verified) on 11 October 2024 - 15:39
Human medicines European public assessment report (EPAR): Halaven, eribulin, Date of authorisation: 17/03/2011, Revision: 31, Status: Authorised
PSUSA/00002345/202312
Submitted by Anonymous (not verified) on 11 October 2024 - 15:28
PSUSA/00002345/202312
Veterinary medicines European public assessment report (EPAR): Purevax RCPCh FeLV, vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia, feline leukeamia and feline Chlamydophila infections, Status: Authorised
Submitted by Anonymous (not verified) on 11 October 2024 - 15:23
Veterinary medicines European public assessment report (EPAR): Purevax RCPCh FeLV, vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia, feline leukeamia and feline Chlamydophila infections, Status: Authorised
Human medicines European public assessment report (EPAR): Qinlock, ripretinib, Date of authorisation: 18/11/2021, Revision: 6, Status: Authorised
Submitted by Anonymous (not verified) on 11 October 2024 - 15:21
Human medicines European public assessment report (EPAR): Qinlock, ripretinib, Date of authorisation: 18/11/2021, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Erelzi, etanercept, Date of authorisation: 23/06/2017, Revision: 17, Status: Authorised
Submitted by Anonymous (not verified) on 11 October 2024 - 15:20
Human medicines European public assessment report (EPAR): Erelzi, etanercept, Date of authorisation: 23/06/2017, Revision: 17, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Purevax RCPCh, Vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia and feline Chlamydophila infections, Status: Authorised
Submitted by Anonymous (not verified) on 11 October 2024 - 15:13
Veterinary medicines European public assessment report (EPAR): Purevax RCPCh, Vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia and feline Chlamydophila infections, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Innovax-ND-ILT, Marek's disease vaccine, Newcastle disease vaccine & infectious laryngotracheitis vaccine (live recombinant), Status: Authorised
Submitted by Anonymous (not verified) on 11 October 2024 - 14:50
Veterinary medicines European public assessment report (EPAR): Innovax-ND-ILT, Marek's disease vaccine, Newcastle disease vaccine & infectious laryngotracheitis vaccine (live recombinant), Status: Authorised
Clinical evaluation of therapeutic radiopharmaceuticals in oncology - Scientific guideline
Submitted by Anonymous (not verified) on 11 October 2024 - 13:37
Clinical evaluation of therapeutic radiopharmaceuticals in oncology - Scientific guideline
Orphan designation: adenovirus associated viral vector serotype 5 containing the human pde6β gene Treatment of retinitis pigmentosa, 19/06/2013 Positive
Submitted by Anonymous (not verified) on 11 October 2024 - 13:29
Orphan designation: adenovirus associated viral vector serotype 5 containing the human pde6β gene Treatment of retinitis pigmentosa, 19/06/2013 Positive